As seen in Table 1, high levels of SLC19A1 mRNA expression were significantly associated with MYCN amplification in both cohorts (Fisher's exact, P = 0.015 and P < 0.001 for the 42 and 650 tumor cohorts, respectively). The gene discussed is MYCN; the disease is neoplasm.